Investigation of reduced susceptibility to glycopeptides among meticillin-resistant Staphylococcus aureus recovered in Ireland (1998-2004)
Citation:
Margaret Fitzgibbon, 'Investigation of reduced susceptibility to glycopeptides among meticillin-resistant Staphylococcus aureus recovered in Ireland (1998-2004)', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical Microbiology, 2009, pp 345Download Item:
Abstract:
Meticillin-resistant Staphylococcus aureus (MRSA) isolates (n=3,189) from 2990 patients were studied by agar screening and the E-test™ macromethod to investigate reduced susceptibility to glycopeptides among six collections of MRSA recovered between 1998 and 2004. No vancomycin-resistant S. aureus or glycopeptide-intermediate S. aureus (GISA) were detected but 178 isolates were confirmed by vancomycin population analysis profile (PAP)-area under the curve (vPAP-AUC) ratio determination and/or teicoplanin PAP (tPAP) methods as hetero-GISA (hGISA). Of 139 isolates detected using recommended E-test™ macromethod cut-off values of ≥8 mg/L for both vancomycin and teicoplanin or ≥12 mg/L for teicoplanin alone, 73 were confirmed as hGlSA by vPAP- AUC, 95 by tPAP and 108 by both methods. Lowering the teicoplanin E-test™ macromethod cut-off value to 8 mg/L detected a further 70 hGISA (17 were confirmed by vPAP-AUC and 70 by tPAP).
Author: Fitzgibbon, Margaret
Advisor:
Rossney, AngelaQualification name:
Doctor of Philosophy (Ph.D.)Publisher:
Trinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical MicrobiologyNote:
TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ieType of material:
thesisCollections
Availability:
Full text availableMetadata
Show full item recordLicences: